CRISPR Therapeutics To Present At The Stifel 2016 Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today announced Rodger Novak, M.D., Chief Executive Officer and Founder of CRISPR Therapeutics, will present at the Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at the Lotte New York Palace Hotel, New York.

Event: Stifel 2016 Healthcare Conference

Date: Tuesday, November 15, 2016

Time: 11:45 AM ET

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors & Media section of the Company's website at www.crisprtx.com.

About CRISPR TherapeuticsCRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.
MEDIA CONTACTS:Jennifer PaganelliW2O Group for CRISPR347-658-8290 jpaganelli@w2ogroup.comINVESTOR CONTACT:Chris BrinzeyWestwicke Partners for CRISPR339-970-2843 chris.brinzey@westwicke.com 

Primary Logo